Shopping Cart (0)
My Account

Your Shopping Cart
Chemcon2014Prognostic, Predictive, and POC: Biomarkers from Research to ClinicFlow Chemistry IndiaMicrofluidics and Lab on a Chip IndiaDiagnostics & Biomarkers - Online Event20% Discount OfferePoster Award PrizeBlogs

Cellular Therapy and Cord Blood 2013 Market Report

Publisher: Select Biosciences
Published: February 2013
Pages: 172 pages PowerPoint Main Report Plus Associated Data in Excel File

Price:



This is the most up-to-date market report focusing on Cellular Therapy and the HSCT/Cord Blood Market Landscape, published by Select Biosciences.

In this comprehensive market report, we have focused primarily on quantitative market metrics in order to characterize the growth and evolution of the cellular therapy field--in this vein, we present primary industry data that Select Biosciences has collected as part of its continual industry tracking of this space.

We've analyzed clinical trial trends and the evolution of several therapeutics areas within cellular therapy [orthopedic, skin/wound care, cardiovascular, and CNS disorders] and present the current status of every single program within the preclinical through the various clinical trial phases and onto commercialization.  We also present the breakout of clinical trials in the bona fide cellular therapy sector with respect to geographic breakout, breakout by type of cells utilized, and disease classes interrogated.

Select Biosciences has also provided a detailed quantitative analysis of the cord blood field as it is rapidly evolving.  Our coverage provides hard numbers on sizes of the various registries, the TNC breakouts of banked units, detailed cost breakouts for banking as well as HSCTs utilizing cord blood.  Furthermore, given our global footprint, we've been able to compare the EU and US markets side-by-side in this analysis.

Select Biosciences also presents the ATMP regulatory guidelines governing the marketing authorization of cellular therapeutics in the European Union.  Details on the statute as well as implications to companies seeking to navigate this space are provided.

This Report is Written and Delivered to Customers in PowerPoint Format allowing convenient drag-and-drop for business plans, R&D presentations, investor presentations.  Report purchasers receive full commercial rights to use the data and analyses presented in the report for their in-house business activities.

Extensive Market Analyses Presented in this Report:

  • Regenerative Medicine and Stem Cell Research Activity in the US
  • Sales of Commercial Products and Services in Stem Cell/Regenerative Medicine Sectors
  • Breakout of Spending by Companies in the Cellular Therapy/Regenerative Medicine Space
  • Breakout of Spending by Product Platforms in Various Spaces
  • Autologous vs. Allogeneic Business Models in the Cellular Therapy Space
  • Autologous vs. Allogeneic Cellular Therapy: Industry SWOT
  • Adult Stem Cell Therapy Quantitative Market Forecast
  • Cellular Therapy Product Pipeline
  • Clinical Trials Quantitative Metrics and Detailed Breakout by Phase, Cell Type, Therapeutic Areas Addressed, Geography
  • HSCTs Performed in the EU: Percent Breakout by Disease Classes Addressed
  • Indications for HSCTs in North America: Disease Classes Addressed, Age of Recipients, Types of HSCs Utilized, Classes of Transplant Inoculum
  • Cost Analyses of HSCTs in the EU vs. US Markets
  • Cord Blood Banking Quantitative Market Metrics
  • Growth of BM, PBL, and CB Units Worldwide in Public Banks and Registries, Segmented by Country
  • Cord Blood Transplantation Trends: Age of Recipient, Disease Classes Addressed
  • EU and US Cord Blood Transplantation Detailed Cost Breakouts
  • EU ATMP Regulation Detailed Analysis
  • Stem Cells Worldwide Publications Analysis

Report Table of Contents (TOC) [Click Here to Download PDF File]

Sample Pages from the Market Report [Downloadable PDF File]


For enquiries about this market report, please contact Kathy Gray at Kathy.Gray@Selectbiosciences.com

Conference News
Bioimaging Asia - Biological Imaging - Call for papers
Bioimaging Asia - Biological Imaging - Call for papers
Bioimaging Asia is taking place the 24-25 September 2015 in Singapore. Submit your abstract for consideration now.


International Bioprinting Congress 2014 - Testimonial
Dr. Vladimir Mironov, Visiting Professor, Centre for Information Technology Renato Archer, Brazil. The most exciting conference I have ever attended. Very inspiring and very well organised.


Keynote Speaker Confirmed, Emmanuelle Charpentier
We are thrilled to announce that Emmanuelle Charpentier, Head of the Department Regulation in Infection Biology at the Helmholtz Centre for Infection Research, Hannover Medical School, has confirmed that she will be giving a keynote presentation at Genome Engineering 2015.


Call for papers - Clinical Applications of Stem Cells 2015
Call for papers - Clinical Applications of Stem Cells 2015
We are now accepting papers for the Clinical Applications of Stem Cells meeting which will take place on the 26-27 of February 2015 in Singapore.


Keynote Speaker Confirmed, Marcie Glicksman
We are thrilled to announce that Marcie Glicksman, Co-Director of the Lab for Drug Discovery, at the Harvard NeuroDiscovery Center, has confirmed she will be giving a keynote presentation at Academic Drug Discovery 2015.


Call for papers - Advances in qPCR and dPCR 2015, Singapore
Call for papers - Advances in qPCR and dPCR 2015, Singapore
We are now accepting papers for the Advances in qPCR and dPCR meeting which will take place on the 21-22 May 2015 in Singapore.

Scroll Up
Scroll Down
Keep me updated Select Bio Blog LinkedIn Twitter LabTube.tv SBOnDemand.com MarketReports.com Research-Store.com